… Cannabinoids and endocannabinoids hold promise for use as disease modifiers and
therapeutic agents … can play a role in many other neurological disorders and diseases. …

… endogenous cannabinoids seems to be a promising alternative for the production of new
drugs… be more explored in order to recognize new and potential effects of antiAD cannabinoids. …

… discover and investigate new cannabinoid ligands, particularly … , digestion failure, neurological
disorders, and psycho(social)… stages of cannabinoid history are extremely promising and …

… would be a promising approach for treating AD symptoms. Agents targeting serotonergic
system … Thus, there are cannabinoid and orexin related agents in clinical trials to modulate the …

… promise as a relevant therapeutic strategy for Parkinson’s … today for the treatment of central
nervous system diseases[43], … , new drugs could possibly be designed for the cannabinoid …

Promising use of metformin in treating neurological disorders… to be repurposed to treat
neurological disorders by correcting … effects observed with direct cannabinoid receptor agonists or …

… Among them, cannabinoid compounds appear as a new … deprivation has provided promising
results in experimental … nervous system diseases, such as multiple sclerosis, traumatic …

… , the cannabinoid system has been the object of growing interest for the treatment of AD.
This signaling system is strongly affected by AD patients, with the cannabinoid receptor CB1 …

… a promising option which may fit these criteria. While regulated temperature reduction has
displayed great promise in preclinical studies of brain … Neurological disorders such as stroke …

… that are being studied include cannabinoid derivatives, and … emerges as a promising
welltolerated treatment option for … with various underlying neurologic disorders including multiple …